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the HSE. It provides help to research establishments and academia on how to comply with their occupational 
health and safety legal obligations; it also provides additional information to help make improvements to health 
and safety systems when working with nanomaterials.  
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Disclaimer 
This document and the information contained within are provided for informational purposes. It is not 
intended to substitute for the statutory requirements for workplace health and safety management. 
The information in this document is provided "as is" and without warranties of any kind.  The UK 
NanoSafety Partnership Group (UKNSPG) assumes no responsibility or liability arising from the use 
of  this  document.    Mention  of  any  company  or  product  does  not  constitute  endorsement  by  the 
UKNSPG.  All Web addresses referenced in this document were accessible as of the publication date.   
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Foreword by Judith Hackitt CBE 
As an engineer myself, I find the new technological developments taking place around us today very 
exciting. 
When we consider the challenges which face our own and future generations on this planet there is 
no  doubt  at  all  that  we  need  the  very  best  of  scientific  and  technological  innovation  to  provide 
solutions in healthcare, medicine, energy, climate change, transport and just about every other aspect 
of the unsustainable way we live our lives today.  Nanomaterials have potential application in all of 
these fields.  
As a regulator, HSE sees its role as enabling business to develop and grow while influencing health 
and safety issues in the development and introduction of new technologies.  We all recognise that 
there are many benefits offered by nanomaterials and that understanding and managing the risks they 
may pose is vital to enabling them to be developed to their full potential. 
Partnership working brings together key players in workplace health and safety who are "part of the 
solution".  The  UK  NanoSafety  Partnership  Group  brings  together  key  experts  in  the  field  of 
nanotechnology and helps to establish links with others who have interests in this fascinating area.  I 
hope  to  see  the  Partnership  Group  continue  in  the  future  and  expand  to  include  industry 
representation.   
Judith Hackitt CBE 
Chair of the Health and Safety Executive 
 
 
 
 
 
Endorsement 
'This guidance has been produced by The UK NanoSafety Partnership Group with contributions from 
the  HSE.  It  provides help to  research  establishments  and  academia on  how  to  comply  with  their 
occupational health and safety legal obligations; it also provides additional information to help make 
improvements  to  health  and  safety  systems  when  working  with  nanomaterials.  It  should  be 
noted that the guidance may go further than the minimum you need to do to comply with the law. 
HSE welcomes  the  launch  of  this guidance and  will  continue  to  work  with partners  to  ensure 
that the health  and  safety  risks  to  employees  in  the  nanotechnologies  industry  are  properly 
controlled.' 
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Scope of Guidance 
1  This Guidance Note draws attention to the possible health hazards which could result from 
exposure to  particulate nanomaterials. It gives advice on the precautions that may be needed to 
prevent  or  adequately  control  exposure  as  required  by  the  Control  of  Substances  Hazardous  to 
Health Regulations (COSHH) 2002 (as amended). 
2  The  aim  of  this  document  is  to  give  guidance  on  factors  relating  to  establishing  a  safe 
workplace and good safety practice when working with particulate nanomaterials. The document is 
applicable to a wide range of nanomaterials, including particles, fibres, powders, tubes and wires as 
well as aggregates and agglomerates.. 
3  This guidance is aimed at employers, managers, health and safety advisors, and users of 
particulate  nanomaterials in research and development. It should be read in conjunction with the 
Approved Code of Practice on COSHH, together with the other literature referred to below and in the 
Appendices. 
4  The document has been produced taking account of the safety information currently available 
and  is  presented  in  the  format  of  guidance  and  recommendations  to  support  implementation  of 
suitable protocols and control measures by employers and employee by advocating a precautionary 
strategy to minimise potential exposure. It is intended that the document will be reviewed and updated 
on a periodic basis to keep abreast of the evolving nature of the content.   
5  This document is applicable to a broad set of nanomaterials that include nano-objects such as 
nanoparticles,  nanopowders,  nanofibres,  nanotubes,  nanowires,  as  well  as  aggregates  and 
agglomerates of these materials.  
6  The term ‘particulate nanomaterials’ used in this document, applies to these entities, either in 
their original form or incorporated into materials or preparations from which they could be released. 
 
Terms and Definitions 
7  The  terms  and  definitions  used  in  this  document  are  based  on  internationally  accepted 
definitions wherever possible, specifically those defined by the European Commission (EC) and the 
International Standards Organisation (ISO). For the purposes of this document, the following terms 
and definitions apply: 
Nanomaterial:    as  defined  by  the  European  Commission  (EC,  2011):  a  natural,  incidental  or 
manufactured material containing particles (nanomaterials), in an unbound state or as an aggregate 
or as an agglomerate and where, for 50% or more of the particles in the number size distribution, one 
or  more  external  dimensions  is  in  the  size  range  1  nm  -  100  nm.  In  specific  cases  and  where 
warranted  by  concerns  for  the  environment,  health,  safety  or  competitiveness,  the  number  size 
distribution threshold of 50% may be replaced by a threshold between 1 and 50%.” By derogation, 
fullerenes, graphene flakes and single wall carbon nanotubes with one or more external dimensions 
below 1 nm should be considered as nanomaterials. 
Within this definition of nanomaterials, the terms "particle", "agglomerate" and "aggregate" are defined 
as follows:  
"Particle" means a minute piece of matter with defined physical boundaries;  
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"Agglomerate" means a collection of weakly bound particles or aggregates where the resulting 
external surface area is similar to the sum of the surface areas of the individual components; 
"Aggregate" means a particle comprising strongly bound or fused particles. 
Nanofibre: nano-object with two similar external dimensions in the nanoscale and the third dimension 
being significantly larger [ISO/TS 27687, def. 4.3]. 
Nano-object: material with one, two or three external dimensions in the nanoscale [ISO/TS 27687, 
def.2.2]. 
Nanoparticle: nano-object with all three dimensions in the nanoscale [ISO/TS 27687, def. 4.1]. 
Nanoplate: nano-object with one external dimension in the nanoscale and the two other external 
dimensions significantly larger [ISO/TS 27687, def. 4.2].  
Nanoscale: size range from approximately 1 nm to 100 nm  [ISO/TS 27687, def. 2.1]. 
Nanotube: hollow nanofibre [ISO/TS 27687, def. 4.4]. 
Particulate  nanomaterial(s):  nanomaterials  that  consist  of  nano-objects  such  as  nanoparticles, 
nanopowders, nanofibres, nanotubes, nanowires, as well as aggregates and agglomerates of these 
materials either in their original form or incorporated in materials or preparations, from which they 
could be released. 
 
Introduction 
8  It  is  widely  accepted  that  there  is  a  crucial  need  for  further  information  and  knowledge 
concerning  the  implications  of  manufactured  particulate  nanomaterials  on  human  health  and  the 
environment. Concerns regarding potential risks to health that may arise during the manufacture, 
manipulation, use and disposal of these materials have been voiced over the past few years. Notably, 
the seminal report from the Royal Society and Royal Academy of Engineering published in 2004 
entitled  “Nanoscience  and  nanotechnologies:  opportunities  and  uncertainties”  (RS/RAEng  2004) 
described emerging concerns regarding the potential risks to health associated with nanotechnology 
and  exposure  to  nanomaterials.    Other  reports,  including  those  from  the  Royal  Commission  on 
Environmental Pollution (RCEP, 2008), the UK’s Health & Safety Executive (see reports available at 
www.hse.gov.uk/nanotechnology/research.htm) and the UK’s Department for Environment, Food & 
Rural Affairs (see reports available at www.defra.gov.uk/environment/quality/chemicals/) have further 
depicted the concerns and have gone someway to helping to address them. However, the increasing 
volumes of particulate nanomaterials that are being produced and introduced into commerce have 
resulted in an urgent need to address exposure and risk assessment data gaps.  
9  This document has been developed in collaboration between the UK Nanosafety Partnership 
Group and the Health and Safety Executive. It is recognised that the field of nanotechnology is rapidly 
expanding and transcends the traditional academic discipline boundaries and incorporates a wide 
range of products, production processes and uses. The document is primarily concerned with the use, 
storage  and  disposal  of  particulate  nanomaterials.    It  does  not  deal  with  incidental  release  of 
nanomaterials such as those from diesel exhaust and welding fumes. 
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Legal Duty  
10  The  occupational  use  of  nanomaterials  is  regulated  under  the  Control  of  Substances 
Hazardous to Health (COSHH) Regulations  2002 (as amended). 
11  COSHH requires employers to protect workers from exposure to harmful substances in the 
workplace.  Embodying  the  principles  of  proportionality  and  risk  assessment,  COSHH  enables 
employers to make a valid decision about the measures necessary to prevent or adequately control 
the exposure of their employees. 
12  The chemical and physical properties of some particulate nanomaterials means that they can 
give rise to a risk of fire and explosion, depending on how they are handled or used. If this is the case, 
the principle legislation applying to the control of substances that can cause fires and explosions in 
the workplace is the Dangerous Substances and Explosive Atmospheres Regulations 2002 (DSEAR). 
13  DSEAR  requires  that  risks  from  dangerous  substances  are  assessed  and  eliminated  or 
reduced so far as is reasonably practicable. The principle of risk assessment applies under these 
regulations. 
14  The Registration, Evaluation, Authorisation & CHemicals (REACH) regulation is the key piece 
of EU-wide legislation, which regulates chemicals substances, including nanomaterials. 
 
Exposure Risk and Hazardous Properties of Nanomaterials 
15  Exposure  to  some  particulate  nanomaterials  can  occur  by  ingestion,  skin  penetration  or 
inhalation,  with  the  resultant  adverse  effects  depending  upon  the  size,  dose  and  toxicity  of  the 
nanoparticle. Toxicity investigations indicate that the effects appear to be related to the total surface 
area of the particles. The exposure potential will be directly related to the structure and form of the 
nanomaterial.  The  exposure  risk  to  particles  encapsulated  in  a  matrix  or  strongly  adhered  to  a 
substrate will be lower than that from ‘free’ aerosolised, particulate nanomaterials.  
16  Some  particulate  nanomaterials  may  have  inherent  hazardous  properties  and  may  be 
classified as carcinogens or mutagens. They may also have other hazardous properties such as toxic, 
harmful  etc,  as  classified  in  the  Chemicals  (Hazard  Information  and  Packaging  for  Supply) 
Regulations  2002.  It  is  generally  agreed  that  the  current  knowledge  regarding  the  toxicity  of 
particulate nanomaterials is incomplete and current safety data sheets may not adequately contain all 
the required safety information. Hence at present it is essential that a precautionary approach be used 
when uncertainties are encountered during exposure risk assessment. 
17  Fire and explosions from dust clouds of organic, inorganic and metallic substances are well 
known.  The potentially higher surface area and reactivity of particulate nanomaterial powders means 
that this safety hazard should be seriously considered and addressed in risk assessments. 
Risk Management Principles 
18  It is important to emphasise that existing legislation in the form of the Control of Substances 
Hazardous to Health (COSHH) regulations will always apply to workplace activity involving particulate 
nanomaterials. The guidance and recommendations given in this document closely mirror the eight 
principles of good practice associated with the COSHH risk assessment process.  
19  Nanomaterials are not necessarily intrinsically hazardous per se but there is a need to take 
specific considerations into account during their risk assessment. Therefore one purpose of the above  
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definition  is  to  provide  clear  and  unambiguous  criteria  to  identify  materials  for  which  such 
considerations apply. The process of risk assessment is the most suitable and systematic means to 
determine which hazard and exposure controls (i.e. risk management measures) are required. 
20  In general, the potential risks to health from particulate nanomaterials can be reduced by safe 
handling and control of exposure. Whilst no single piece of guidance can provide a definitive, step-by-
step  approach  to  safe  handling  of  all  nanomaterials  in  all  circumstances,  there  are  a  number  of 
general and specific best practice guides that can be used in most applications.  
21  The general approach for safe handling and control of particulate nanomaterials is similar to 
that for other types of chemical substances and seeks to: 
  Identify the hazards and assess the risks. 
  Decide what precautions are needed. 
  Prevent or adequately control exposure. 
  Ensure that control measures are used and maintained. 
  Monitor the exposure. 
  Carry out appropriate health surveillance. 
  Prepare plans and procedures to deal with accidents, incidents and emergencies; and 
  Ensure employees are properly informed, trained and supervised. 
 
Nanomaterials’ Characterisation 
Background and challenges 
22  Characterisation of nanoparticles plays an essential role in a variety of overlapping contexts 
ranging from fundamental and applied research, through process and product quality control and 
commercialisation  to  health  and  environmental  protection.  Fibre-like  particles  present  distinct 
challenges when characterised using many of today’s routine measurement techniques that focus on 
spherical particles.  Moreover, not all particles with the same ‘apparent’ composition have the same 
potential to cause harm. As with other chemical substances, appreciation of the relationship between 
the wide range of physico-chemical characteristics of nanomaterials is important in understanding 
their  toxicology.  The  implementation  of  reliable  findings  from  experimental  studies  into  regulatory 
frameworks with the objective of protecting human and environmental health is also subject to the 
limitations of inadequately characterised materials and the complexity of mixtures of particles in ‘real 
world’ exposures.  
23  Nanomaterials may exhibit properties and behaviour that are very different from the bulk-scale 
materials of the same chemical identity. Knowledge of their size, shape and surface-related properties 
can be used to account for many of the observed differences. It is widely acknowledged that adequate 
characterisation of a nanomaterial is therefore necessary to accompany any toxicity study, particularly 
in  cases  where  particulate  nanomaterials  (e.g.  carbon  nanotubes)  can  be  produced  by  different 
processes yielding notionally the same material, but which exhibit quite different properties.    
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24  It is important to recognise that no individual technique can provide an entirely holistic and 
meaningful characterisation of the sample. Multiple techniques are required to formulate as complete 
an understanding of the nanomaterial’s properties as necessary. Different techniques will suit different 
sample forms (e.g. aerosol, suspension etc.) and the optimum set of required techniques should be 
selected based on the specific nanomaterial type, form under investigation and purposes of the study. 
25  A further important challenge is how representative the sample is of the material, which may 
be influenced by the surrounding environment and may change as a function of time. 
Selection of properties and techniques for characterisation 
26  It is important to recognise that complete characterisation of test materials is time consuming, 
expensive,  complex  and  may  never  be  fully  achievable.  The  degree  of  characterisation  required 
depends on the needs or objectives of the study, which can include informing a hazard exposure 
assessment and overall risk posed by a material.  Researchers in the field of nanosafety generally 
agree however that information on a number of fundamental properties needs to be gathered. These 
currently include, but are not necessarily limited to composition, size and shape, state of dispersion, 
surface area and surface chemistry. Any regulatory requirements for characterisation also need to be 
met.   
27  A range of techniques have been adapted or developed for the characterisation of particulate 
nanomaterials, including microscopic, spectroscopic, spectrometric and chromatographic methods.  It 
is beyond the scope of this document to provide guidance on all properties and techniques.  Several 
reviews  and  publications  are  available  that  can  provide  appropriate  details,  as  highlighted  in  the 
Further Reading.  The selection of an appropriate technique depends on the type of material, the 
required characterisation and the resolution/quality of the data needed.   
28  Taking the example of hazard assessment, there is consensus that thorough and accurate 
particle  characterisation  are  an  essential  part  of  assessing  the  potential  toxicity  of  particulate 
nanomaterials in biological systems. Information is required on the response to the material against a 
range of potentially relevant dose metrics, including mass, surface area and number concentration.  
Appropriate characterisation of test materials is important to ensure that the results are reproducible 
(within and between laboratories), and also to provide the basis for understanding the properties of 
particulate  nanomaterials  that  determine  their  biological  effects.  Some  of  the  key  parameters 
influencing the biological activity of particulate nanomaterials remain to be fully understood at this 
point in time. Any study however conducted with material that has not been characterised with respect 
to a property later found to be critical for toxicity will ultimately be of little value. 
29  A rationale, exemplified for hazard assessment above, should be developed and documented 
that meets the characterisation requirements.  It is recommended that best practices advocated in 
published standards and guidance for nanoparticle characterisation should be adopted. 
 
Toxicology 
30  As a crucial and integral part of the risk assessment framework, the understanding of the 
hazard potential of a substance is important and this is established on the basis of a toxicological 
assessment. The quantity and quality of toxicological data available dictates the robustness and how 
informed a hazard assessment can be and this can vary markedly from well-established substances 
for which a great deal of information exists (e.g. NaCl) to substances that are early in development 
(e.g. graphene platelets) for which there is little data.   
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31  The way in which different information levels can affect the type of assessment that can be 
performed is shown in Figure 1 and the development and adoption of an Occupational Exposure Limit 
(OEL)  from  a  human  safety  point  of  view  is  the  most  robust  outcome,  but  this  requires  a 
correspondingly  high  level  of  data  (e.g.  well-designed  in  vivo  inhalation  studies  of  a  sufficient 
exposure period performed to internationally recognised guidelines). However for many substances  
(not  just  nanoparticles),  such  information  is  not  available  and  instead  lower  level  toxicological 
assessments  must  be  used  with  a  corresponding  increase  in  uncertainty  and  margin  for  error 
dependent on the data available. 
32  Considering  the  scheme  in  Figure  1  in  relation  to  nanomaterials,  the  level  of  available 
toxicological data for most nanomaterials is within the Minimal to Suggestive range with very few 
nanomaterials possessing what could be considered Adequate information (e.g. TiO2). Therefore, for 
a large number of nanomaterials, a hazard/control banding approach is considered the most practical 
solution  in  the  absence  of  data  for  an  OEL.  It  must  however  be  recognised  that  hazard/control 
banding approaches for nanomaterials are still very much in the development stage and have not yet 
been validated. 
 
Figure 1: Illustrative example of the level of toxicological data required determining an OEL or using lower level 
banding approaches (re-drawn from Schulte et al, 2011). 
33  When  considering  the  hazard  potential  of  particulate  nanomaterials,  it  is  important  to 
understand  that  the  word  “nanoparticles”  embraces  an  enormous  variety  of  different  materials  in 
different compositions, shapes and sizes (with one or more aspect in the nanometre range). There is 
therefore no single measure of toxic potency that can be attributed to all nanoparticles since there can 
be considerable variability in toxicity based upon physico-chemical characteristics; specifically, not all 
nanoparticles are toxic nor equally hazardous. Furthermore, it is important to note that the definition of 
Available 
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the size cut-off for nanoparticles has no basis in toxicology, meaning that there is no step-change in 
toxicity when a particle becomes below 100 nm in any dimension. 
34  When searching for hazard information, it is absolutely necessary to define the nanoparticles 
that  are  under  consideration  in  as  much  detail  as  possible  (see  Nanomaterials’  characterisation 
section). For example, “zinc oxide nanoparticles” or “carbon nanotubes” are very broad descriptions, 
and it would be better to give details such as “20 nm uncoated ZnO nanoparticles” or “multi-walled 
carbon nanotubes, in fibre form, with length range 620 nm – 52 µm, and 12% iron” as this enables a 
greater depth of consideration when attempting to describe the potential potency or toxic behaviour. 
Hazard Information 
35  There is now an evidence base of toxicology of various nanoparticles showing considerable 
differences in hazard between different nanoparticle types. However, the literature is dominated by 
studies that employ non-validated in vitro tests, which form an unsuitable basis for risk assessment in 
part  because  the  relationship  between  in  vitro  toxicological  data  and  in  vivo  effects  is  unclear. 
Currently,  there  are  very  few  inhalation  studies  on  which  to  base  the  development  of  OELs  for 
nanoparticles  and  those  that  do  exist  are  limited  to  a  small  number  of  nanoparticles  with  limited 
relevance to other forms of nanomaterials. 
36  This  means  that  for  the  majority  of  nanoparticles  there  is  unlikely  to  be  the  in-depth 
quantitative toxicological data required for the determination of an OEL. Therefore, when such a limit 
is presented within an MSDS, one should question if it is specifically for the nanoparticle in question, 
or if it relates to the bulk compound or an analogous material (e.g. an OEL for graphite being given for 
CNT) when it is unlikely to be accurate. 
37  When looking rather generally at the current, large toxicological evidence base across a wide 
breadth of nanoparticles, it seems that: 
  Many nanoparticles are likely to pose a low hazard at plausible exposures to the lungs. 
  The skin is unlikely to be affected by the common nanoparticle types, which do not cross into 
the human body through skin to any significant extent. 
38  These are broad generalisations taken on balance, but it has been shown that some highly 
toxic nanoparticles such as ZnO nanoparticles might adversely affect the lungs if there is on-going 
high  exposure.  In  addition,  there  are  special  cases  of  particulate  nanoparticles  that  might  pose 
unusual hazards due to their novel and unusual properties which do not arise in nature. This includes 
long (>15 µm) nanofibres and nanotubes, low density “fluffy” nanotube bundles and large but very thin 
plate-like particles, all of which are large but with small aerodynamic diameters so that they are not 
dealt with by normal mechanisms. 
39  Below  are  listed  several  attributes  in  the  form  of  questions  that  may  infer  toxicity  to 
nanomaterials and as such, the presence of one or more of these physico-chemical characteristics 
may suggest increased hazard potential.  (Inclusion here is based upon generalisations and intended 
to help inform as to the potential risks and should not be seen as a replacement for robustly derived 
OELs if available.) 
  Is the particulate classified as a CMTR (carcinogens, mutagens, teratogens and reproductive 
toxicants) or sensitizer? 
If the bulk or parent version (if it exists) of a nanomaterial is already classified as a CMTR or 
skin/respiratory  sensitizer,  there  is  a  high  likelihood  that  the  nanoparticulate  form  will  also 
demonstrate  this  toxic  potential.  Indeed  due  to  their  characteristically  large  surface  area,  the  
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nanoparticulate form may exhibit comparatively greater activity than that of the bulk compound and 
should therefore be considered as potentially hazardous. 
  Is the nanomaterial composed of reactive metal(s)? Is the nanomaterial photoreactive? Does 
the nanomaterial have a highly charged surface? 
The  presence  of reactive  metals  is known  to  drive  the  toxicity  of  various  complex  particulate 
mixtures such as welding fumes (McNeilly et al, 2004). Therefore a nanomaterial possessing a 
significant proportion of such metals (e.g. large amounts of catalyst remaining within unrefined 
carbon nanotubes) could be regarded as having a potentially hazardous component. 
When exposed to light, photocatalytic nanomaterials (e.g. certain forms of TiO2) can release free 
radicals  (Konaka  et  al,  1999)  that  may  generate  toxicity  by  causing  inflammation,  oxidative 
damage and genetic damage Hirakawa et al, 2004; Carlotti et al, 2009). 
The  surface  charge  of  a  nanomaterial  is  known  to  influence  its  propensity  to 
agglomerate/aggregate, but it can also play a prominent role during cellular uptake or interactions 
with charged molecules such as proteins. 
These attributes, singly or collectively, can contribute to the surface activity of a nanoparticle and 
are potential drivers of toxicity. The combination of high surface area and high reactivity may lead 
to the formation of a “double hazard” Duffin et al, 2007; Karlsson et al, 2009). 
  Is the nanomaterial highly acidic/basic? 
If contact with a nanomaterial leads to a substantial pH change away from the normal range of the 
biological environment at a point of contact (e.g. skin or site of deposition within the lungs), this 
could cause adverse effects. These could include local effects such as skin irritation/corrosion or, 
for example, cell death within the lungs leading to inflammation/oedema/fibrosis. 
  Is the (nano)material soluble? 
The solubility of a (nano)particle can have a positive and/or negative influence on its propensity to 
cause harm. Specifically if a particle is soluble in an aqueous environment but does not release 
toxic components, a progressive reduction/removal of dose will occur as the particle dissolves. 
However  if  the  particle  releases  reactive  or  cytotoxic  components  such  as  toxic  ions  as  it 
dissolves, its toxicity could increase. 
An attribute of nanoscale materials is the potential for changes in physico-chemical characteristics, 
including  solubility,  compared  to  the  bulk  material;  e.g.  bulk  silver  is  insoluble,  but  nano-silver 
releases free silver ions in aqueous solutions by dissolution. Therefore the contention that since 
the bulk material is insoluble, the nanomaterial is also insoluble is not necessarily correct. As such 
when considering the hazardous nature of a material, it is pertinent to consider both the insoluble 
(particle) and soluble components in the hazard assessment. 
  Is the nanomaterial fibrous (i.e. possess a high aspect ratio)? 
There  is  concern  that  fibrous  nanomaterials  such  as  carbon  nanotubes  or  nanowires  may 
represent a similar danger to health as hazardous fibres such as asbestos, refractory ceramic 
fibres  or  certain  man-made  vitreous  fibres  (MMVFs).  The  basis  for  this  is  the  morphological 
similarity  between  these  fibres  and  newly  developed  high  aspect  ratio  (fibrous)  nanomaterials 
(HARN). However if the fibre hazard paradigm is to be enacted, certainty is needed that it is a 
fibrous sample that is being dealt with, i.e. it should meet the criteria of the definition of a fibre, 
such as that of the World Health Organisation (WHO).  
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The WHO defines a respirable fibre as an object with length greater than 5 µm, width less than 3 
µm and length to width ratio (aspect ratio) greater than 3:1 (WHO, 1997). Those particles which do 
not meet these base criteria would not be considered as fibres and are unlikely to represent a fibre-
type hazard (although they may still represent a particulate-type hazard). Within fibre toxicology, a 
fibre begins to generate difficulties with normal clearance mechanisms in the lung when its length 
prevents  its  full  enclosure  by  those  cells  tasked  with  clearing  such  particles  (alveolar 
macrophages). This is considered to be between 15-20 µm in length (Donaldson et al, 2010). A 
nanomaterial  longer  than  15  µm  would  therefore  potentially  frustrate  clearance  mechanisms  if 
deposited in the distal lung and lead to hazardous effects similar to those associated with other 
harmful fibres. Due to the uncertainty around the identification of a clear length cut-off for harmful 
fibres,  the  WHO  length  criteria  of  5  µm  could  be  seen  as  presenting  a  suitably  conservative 
approach. 
Since generalisations should not be based purely on the substance type when considering the 
potential hazard of a particulate; not all fibrous nanomaterials will necessarily represent a fibre 
hazard as outlined above and not all nanomaterials typically thought of as particulate, always exist 
in particulate form.  For example, not all carbon nanotubes are true fibres, as many form highly 
curled, dense bundles and are particulate in nature. Conversely, not all TiO2 nanoparticles are 
particulates, since like many materials, it can be formed into wires (Hamilton et al, 2009) which 
could  represent  a  fibre  hazard.  It  is  therefore  imperative  that  the  true  physico-chemical 
characteristics of the sample under consideration (and not just of the class of material) be 
established when considering the basis for hazard. 
  Does the nanomaterial possess a low aerodynamic diameter yet one or more high aspects? 
As the basis for respiratory toxicity from fibres requires a low aerodynamic diameter for penetration 
into the distal airways yet a large physical aspect (e.g. fibre length or particle diameter), it is worth 
bearing  in  mind  that  other  shapes,  not  just  fibres,  can  possess  these  properties.  Plate-like 
structures such as grapheme/graphite platelets can have a very large (>15 µm) diameter yet be 
very thin (<100 nm) and as such possess a low aerodynamic diameter (Sanchez et al, 2011), 
allowing them to be respirable. In addition, low density ‘fluffy’ bundles of fibres, often seen with 
carbon nanotubes, may also, due to their very low density, possess the potentially hazardous mix 
of low aerodynamic diameter with one or more high aspects, making clearance from the distal lung 
difficult. However much more research is needed into these particle types to understand if they are 
likely to represent a true hazard to humans. 
 
Hazard Banding 
40  As discussed above, the currently available toxicology data for the majority of nanomaterials 
would be considered as Minimal or Suggestive and this is incompatible with the development of an 
OEL (Figure 1). As a practical interim solution to aide in the risk assessment of such materials, a 
hazard and control banding approach could be utilised. 
41  Hazard banding as an approach has been adopted within the pharmaceutical industry with 
early publications on the subject from the mid-1990s (Naumann et al, 1996). It was developed as a 
means  to  deal  with  the  problem  of  the  rapid  development  of  new  compounds  for  which  few 
toxicological data existed. Indeed for some of these compounds, the mechanisms by which they had 
their effects were poorly understood, yet they were becoming increasingly potent with unknown short 
and  long  term  health  effects.  A  practical  approach  to  mitigating  the  risks  associated  with  such 
unknown  compounds  was  to  classify  them  based  on  limited  toxicological  data  into  bands,  which 
inform as to the relative hazard, maximum exposure levels and are aligned with control schemes. This 
would mean in practice that a nanoparticle classed as “highly hazardous” could only be handled within  
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full  contaminant  and  associated  low  airborne  mass  concentration  exposure  limit,  whilst  those 
classified as “low hazard” (e.g. an airborne mass concentration in line with the nuisance dust limit of 
10 mg/m
3) could be handled with good ventilation and appropriate PPE. 
42  A problem equally as relevant to nanomaterials as to chemicals and pharmaceuticals is what 
to do with materials for which no information exists. An approach may be to use “physico-chemical or 
structural  alerts”,  such  as  those  discussed  earlier,  many  of  which  are  incorporated  into  control 
banding tools. Identification of such alerts may suggest a basis for hazard and promote a nanoparticle 
up the category scheme, necessitating tighter controls and exposure measures. Another approach is 
to adopt a default  preliminary  category associated with sufficient exposure control measures that 
would  protect  workers  should  a  compound  later  be  shown  to  be  toxic.  Movement  out  of  such  a 
category would be based upon toxicological evidence to allow its transfer to a lower or higher hazard 
category as appropriate. The latter approach is conservative whilst the former allows a case-by-case 
basis  that  reduces  the  number  of  non-toxic  nanoparticles  being  encumbered  by  what  may 
subsequently be shown to be excessive control methods. 
43  Whilst it is possible to identify some nanoparticles in relation to their hazard (e.g. certain forms 
of TiO2 considered as low hazard), the hazard banding approach is still under development and has 
yet  to  be  validated  for  nanomaterials.  Further  development  as  well  as  expert  and  regulatory 
agreement of the criteria for inclusion of nanoparticles into different bands are required. 
 
Exposure Control 
44  UK and European law requires workplace exposure to substances hazardous to health to be 
controlled adequately. This applies to nanomaterials particularly where there is uncertainty about the 
risk. To achieve adequate control involves applying “good control practice”, which is a consensus 
view of hardware, systems of work and other measures that need to be put in place to control the risk. 
45  An employer’s overriding duty and first priority is to consider how to prevent employees being 
exposed to substances hazardous to health (including nanomaterials) by all routes. Employers who 
do not do this are failing to comply with a fundamental requirement of COSHH. The principles of the 
hierarchy of controls, which is based on inherent reliability and likely effectiveness, should be applied. 
The  duty  to  prevent  exposure  should  be  achieved  by  measures  other  than  the  use  of  personal 
protective equipment. 
Risk Assessment 
46  A  risk  assessment  must  be  carried  out  before  an  employee  is  allowed  to  work  with 
nanomaterials. This risk assessment must be a suitable and sufficient assessment of the risk to health 
caused by the work. The HSE booklet “A step by step guide to COSHH assessment” describes in 
general  terms  the  procedures  to  be  followed  in  making  an  assessment.  The  COSHH  general 
Approved Code of Practice (ACOP) also gives guidance.  
47  Assessment of the risk should include identifying all potential sources of exposure. An action 
plan /check list for assessment would involve addressing the questions: 
  Where are nanomaterials likely to be generated/synthesised etc? 
  Is exposure likely? 
  Who is likely to be exposed? 
  Can the exposure be prevented?  
 
 
© NanoSafety Partnership Group 2012                                                                                                               Page 18  
  If the exposure cannot be prevented, estimate the potential level of exposures. 
48  Work  activities  involving  nanomaterials  which  require  special  attention  when  assessing 
exposure include: 
  Handling of particulate nanomaterials. 
  Manufacturing of nanoparticles (especially production of nanoparticles in a gas phase) and 
associated maintenance of equipment. 
  Machining of materials containing nanoparticles (e.g. sawing, polishing, grinding). 
  Spraying of liquids containing nanoparticles. 
  Processing nanoparticles in a liquid where a high energy output is involved. 
  Waste disposal of all types of nanomaterials. 
49  In making the assessment, careful attention should be paid if there is a possibility of inhalation 
of the particulate nanomaterials. 
50  In all cases, the assessment should be written down and reviewed if circumstances change or 
new information becomes available on the hazard of the nanomaterials being used. 
Prevention and control of exposure 
51  Having made an assessment of the risk from exposure to nanomaterials,  employers  must 
ensure that such exposure is either prevented, or if that is not reasonably practicable, adequately 
controlled. 
52  Employers  need  to  consider  the  following  precautionary  measures  in  their  prevention  and 
control procedures, and adapt them to suit their circumstances. Employers should arrange to review 
regularly the adequacy of the precautions taken, particularly if the circumstances of use change or in 
the light of new technical developments or information on the nanomaterials. 
Prevention of exposure: Substitution 
53  As with all substances potentially hazardous to health, the employer must give first priority to 
preventing workers being exposed to nanomaterials. This can be achieved in a number of ways, for 
example by using a substitute material or process, which does not involve nanomaterials, or by changing 
the method of work. In considering substitution, it is important to take account of any hazards of the 
substitute materials or process and balance the risks these might present against the benefits. More 
guidance is given in the HSE booklet 7 “Steps to successful substitution of hazardous substances”. 
Workplace Exposure Limits 
54  At the time of preparing this guidance, there are currently no UK legal Workplace Exposure 
Limits (WELs) specific for any nanomaterials. Therefore, in compliance with COSHH, the potential for 
exposure should be eliminated or strictly controlled to as low a level as is reasonably practicable. 
55  There have been many references made in the literature to proposed limits. None of these 
limits are based on health effects; some ascertain they are achievable with good control practices; 
others  are  based  on  extrapolation  from  toxicological  studies.  In  the  United  States,  the  National 
Institute  for  Occupational  Safety  and  Health  (NIOSH)  has  issued  a  recommended  occupational  
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exposure limit (REL) for CNTs, but currently there is no legal basis to use these limits in the UK. 
These  limits  should  be  used  with  extreme  caution.  It  should  also  be  noted  that  measuring 
nanomaterials in the workplace is a challenge and there is considerable debate on which metric to 
measure. 
56  It  should  be  noted  that  the  UK  WEL for  airborne  ‘Carbon  Black’  of  3.5  mg/m
3  (3500 
µg/m
3) is not considered appropriate for carbon nanotubes.  
57  Measurement of airborne particulate nanomaterials is not a simple, quick or straightforward 
task  and  therefore  the  preferred/practical  option  in  most  research  environments  is  to  prevent 
potential  exposure  with  rigorous  containment  via  engineering  controls  rather  than  an  extensive 
airborne nanomaterial monitoring regime. 
Approaches to selecting control measures 
58  Several  approaches  may  be  taken  to  identify  the  necessary  control  measures  required to 
prevent  exposure  to  particulate  nanomaterials  in  the  laboratory  and  workplace.  Traditional 
approaches for risk assessment of substances cannot always be applied to all nanomaterials due to 
the missing data or uncertainties with existing information. An alternative approach is the utilisation of 
control  banding,  which  is  a  simplified  approach  to  evaluate  the  risks  from  activities  and  the 
substances they involve into bands according to the potential for exposure and the hazard. For each 
risk band, control measures are then suggested. A number of tools are being developed (Table 1), 
albeit  with  important  assumptions  and  limitations,  which  may  help  inform  the  assessment  and 
management of risks from working with all nanomaterials and indeed other chemical substances. 
Table 1:  Examples of current control banding tools being developed for nanomaterials 
Name  Type  URL 
Precautionary 
Matrix  Risk Prioritisation  http://www.bag.admin.ch/themen/chemikalien/00228/00510/0
5626/index.html?lang=en  
NanoCB Tool  Control Banding  http://www.controlbanding.net/Home.html  
ANSES nano  Control Banding  http://www.afsset.fr/index.php?pageid=2820&parentid=805  
Stoffenmanager 
Nano 1.0  Risk Prioritisation  http://nano.stoffenmanager.nl/  
NanoDafer 
Risk Evaluation 
(semi-
quantitative) 
http://nanosafer.i-bar.dk/  
N.B. These tools have been developed independently of each other and are not standardised. 
This may lead to different outcomes from each model for the same data inputs. 
59  The control banding approach of COSHH Essentials can be applied to nanomaterials. This is 
a  tried  and  tested,  robust  approach  for  many  chemical  hazards,  although  it  is  important  to 
acknowledge  that  there  currently  are  no  COSHH  Essential  control  sheets  for  nanomaterials,  but 
development is on-going.  
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Control of exposure to particulate nanomaterials 
60  Use of good laboratory/good workplace practice is a pre-requisite to controlling exposure to all 
substances  hazardous  to  health.  Where  information  on  the  toxicity  of  a  specific  particulate 
nanomaterial is unknown or unclear, a precautionary approach should be adopted; i.e. it should be 
assumed, until proven otherwise, that the specific particulate nanomaterial represents a hazard to 
health. 
61  Therefore,  wherever  reasonably  practicable,  exposure  to  particulate  nanomaterials  by  all 
routes (inhalation, dermal and ingestion) should be eliminated or controlled by the use of engineering 
controls. If total prevention of exposure to particulate nanomaterials is not reasonably practical, the 
duty under COSHH is to reduce exposure to the lowest reasonably practicable level. (Appendix 2 
shows a particulate nanomaterial control measures selection flowchart). 
62  If  engineering  controls  and  good  laboratory/good  workplace  practice  are  not  adequate  to 
control  exposure,  consideration  should  be  given  to  using  additional  controls,  such  as  respiratory 
protective equipment to prevent inhalation. Whatever system is chosen, there is a need to check that 
it is and remains effective. 
63  In  most  cases  the  principle  potential  exposure  route  to  particulate  nanomaterials  in  the 
laboratory  or  workplace  is  via  inhalation.  Therefore,  wherever  possible  the  release  of  airborne 
particulate nanomaterials should be minimised or prevented by the use of appropriate processes, 
practices, systems and engineering controls. 
Inhalation risk 
64  Where there is a risk of particulate nanomaterials becoming airborne, the following measures 
should be used to control and prevent exposure: 
  Where possible: 
o  Minimise the quantity of particulate nanomaterials in use at any one time. 
o  Minimise the number of people potentially exposed. 
o  Minimise the potential exposure time. 
  Ensure that all those potentially exposed to particulate nanomaterials have had suitable and 
sufficient information, instruction and training. 
  Use  engineering  controls  such  as  Local  Exhaust  Ventilation  (LEV)  to  control  airborne 
exposure. 
  Avoid contact with the skin. Always wear suitable disposable, single-use gloves. 
  Where dust exposure from contamination of work clothing could be significant, use clothing 
made from a low dust-retention and low dust-release fabric. 
  Keep all bottles/vessels containing particulate nanomaterials sealed when not in immediate 
use since it has been shown that the action of opening vessels containing free particulate 
nanomaterials can cause them to be drawn from the vessel so that they become airborne.  
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  Where possible, keep the particulate nanomaterial wet or damp, or use slurries, and avoid 
energetic  processes  that  might  generate  airborne  dusts  or  aerosols  to  reduce  the  risk  of 
particulate nanomaterials becoming airborne. 
  Use  a  damp  sheet  of  paper  towel  or  tissue  on  the  bench  when  weighing  out  particulate 
nanomaterials and dispose of it in a sealed plastic bag whilst it is still damp. 
  Use a damp paper towel or tissue to wipe up spilt particulate nanomaterials and dispose of it 
in a sealed plastic bag whilst it is still damp. 
Dermal and ingestion risk 
65  Where there is a risk of particulate nanomaterials contacting the skin, the following measures 
should be used to control and prevent exposure: 
  Where possible: 
o  Minimise the quantity of particulate nanomaterial in use at any one time. 
o  Minimise the number of people potentially exposed. 
o  Minimise the potential exposure time. 
  Ensure that all those potentially exposed to particulate nanomaterials have had suitable and 
sufficient information, instruction and training. 
  Use engineering controls such as LEV to control airborne exposure. 
  Avoid contact with the skin. Always wear suitable disposable, single-use gloves. 
  Change the disposable gloves after every task. 
  Ensure gloves are removed in a safe manner and disposed of safely. 
  If possible, use instruments/tools to prevent contact with the skin. 
  Good housekeeping is important with easy to clean surfaces, containment of spills and 
keeping the workplace surface clean using wet wipes. 
  Good personal hygiene/skin care is also important; suitable welfare facilities should be 
provided. 
  Use a damp sheet of paper towel or tissue on the bench when weighing out particulate 
nanomaterials and dispose of it in a sealed plastic bag whilst it is still damp. 
  Use a damp paper towel or tissue to wipe up spilt particulate nanomaterials and dispose of in 
a sealed plastic bag whilst it is still damp 
  Always wash hands before leaving the laboratory/work area. 
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Engineering Control Measures 
66  Engineering control measures will vary depending on the requirements of each workplace. It 
may be necessary for those working with particulate nanomaterials to use a combination of methods 
to control exposure. These methods range from total enclosure of the process and automatic handling 
techniques, to partial containment by LEV, such as extracted enclosures and fume cupboards. Total 
enclosure  or  partial  enclosures  such  as fume  cupboards  will  be  reasonably  practicable  for  many 
operations with particulate nanomaterials, including manufacture/synthesis and weighing. For cutting, 
sawing or polishing, simpler extracted enclosures and other LEV devices such as capturing/receiving 
hoods  or  down-draught  benches  may  be  appropriate.  Particulate  nanomaterials  have  also  been 
shown to be captured by electrostatic collectors. However, certain work activities may lead to higher 
potential exposure and therefore additional control measures may be necessary. 
67  All LEV equipment should be designed and installed to a high standard (see HSG 258). 
68  Wherever  reasonably  practicable,  the  exhaust  air  from  an  LEV  system  should  be  filtered 
through  a  High  Efficiency  Particulate  Air  (HEPA)  filter,  preferably  H14,  to  remove  the  airborne 
particulate  nanomaterials  before  venting  to  a  safe  place  outside  the  building.  This  is  particularly 
important when handling HARNs such as carbon nanotubes or other fibrous/rod like nanomaterials. If 
it is not reasonably practicable to vent the exhaust air to a safe place outside, it must never be 
re-circulated directly back into the workplace unless it has been effectively filtered to remove 
airborne particulate nanomaterials by at least one HEPA H14 filter (see Appendix 1). 
HEPA Filtration Efficiency 
69  HEPA  filters  HP14  are  designed  to  remove  at  least  99.97%  of  airborne  particles  with  a 
diameter of 300 nm, which is classically regarded as the Most Penetrating Particle Size (MPPS). 
Larger and smaller particles may be filtered with even higher efficiency. Recent studies indicate that 
HEPA  filters  of  this  grade  are  reasonably  efficient  at  capturing  the  relatively  limited  number  of 
particulate nanomaterials (as small as 2 nm in diameter) tested. It should be noted that different 
grades  of  HEPA  filter  have  differing  efficiencies  in  the  nanoparticle  range.  In  addition,  different 
particulate nanomaterials may have differing MPPSs and penetration rates depending on their shape, 
density and charge. 
70  Ultra Low Particulate Air (ULPA) filters are designed to remove 99.999% of airborne particles 
with  a  diameter  of  120  nm,  but  to  date,  little  information  is  available  on  their  performance  with 
particulate nanomaterials. 
Local Exhaust Ventilation (LEV) 
71  The most effective class of LEV are enclosures. In the laboratory setting there are generally 
two types: full or partial. Full enclosures (e.g. a glove box with HEPA filtration) are the most effective 
as they provide physical separation between the worker and the material. However, their inherent 
features can make them impractical as a control option and therefore partial enclosures are frequently 
used.  These  may  be  designed  specifically  for  the  process  or  be  commercially  available  units. 
Examples of partial enclosures suitable for handling particulate nanomaterials include: HEPA-filtered 
fume  cupboards,  HEPA-filtered  containment  cabinets  or  a  HEPA-filtered  microbiological  safety 
cabinets  (MSCs).  Using  double  HEPA-filtered  cabinets  increases  the  level  of  protection  and  can 
provide a safe means of carrying out filter changes. 
72  The small size and ”low inertia” of particulate nanomaterials means they move with the air 
generated by the process in a manner more akin to gases than conventional particles. Therefore 
correctly designed LEV systems should be an effective control measure.  
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73  The effectiveness of any control measure cannot be automatically assumed when handling 
particulate nanomaterials. Respirators, HEPA-filtered cabinets and most importantly fume cupboards 
were  not  specifically  designed  for  this  task,  and  so  evidence  should  be  sought  as  to  their 
effectiveness before use. For newer installations, information may be sort in the LEV commissioning 
report (see HSG 258 and BS EN 14175). 
74  It is important to make sure that the LEV achieves and maintains adequate control of exposure 
at  all  times.  The  system  requires  regular  maintenance/periodic  monitoring  to  ensure  controls  are 
working  and  thorough  examination  and  testing  “once  a  year”  (COSHH  allows  a  maximum  of  14 
months between tests). In most circumstances, face velocity measurements will suffice, but a smoke 
test will show whether the LEV is truly effective. Furthermore, if a smoke test is performed with the 
process/operation running, it will show: 
  The size, velocity and behaviour of airborne contaminants. 
  The capture zones and boundaries. 
  Whether containment is maintained within the hood. 
  Draughts, their direction and size. 
  The general movement of air around the hood. 
  Eddying and encroachment into the operator’s breathing zone. 
75  If there is any doubt about the capability of a fume cupboard, then it may be necessary to 
carry out a full containment test, as detailed in BS EN 14175-4:2004. 
76  All users should be trained in how to check and use the LEV and records should be kept of all 
the daily, weekly, monthly and annual LEV checks. 
Ducted Microbiological Safety Cabinets (MSCs) 
77  Ducted  MSCs  can  be  used  to  handle  particulate  nanomaterials  in  a  similar  way  to  other 
HEPA-filtered containment cabinets. A Class I MSC operates in a similar way to a fume cupboard and 
protects the worker by drawing air through the front opening. Class II and III MSCs provide protection 
for both the user and the material in the cabinet. All these cabinets exhaust air through a HEPA filter. 
78  It should be noted that Class II MSCs are NOT suitable for handling HARNs and are only 
suitable  for  handling  small  (<1  g)  quantities  of  particulate  nanomaterials  because  they  re-
circulate up to 70% of their air inside the cabinet and are only specified to a containment level 
of 1/100,000. 
Ductless re-circulating HEPA-filtered containment cabinets and re-circulating MSCs  
79  Ductless re-circulating HEPA-filtered containment cabinets and MSCs that “re-circulate” air 
back into the room from the cabinets interior through a HEPA filter, can be used for small quantities 
(<1 g) of particulate nanomaterials in the absence of hazardous vapours or gases. However, the 
use of a ductless re-circulating cabinet or enclosure to control any hazardous substance must be 
subject to rigorous risk assessment and should only be considered where external venting to a safe 
place outside is not reasonably practicable.  The containment cabinet should be set aside for use with 
particulate nanomaterials or chemically similar materials because some other chemicals, particularly 
those  with  the  potential  to  evolve  corrosive  vapours  or  fumes,  may  affect  the  effectiveness  and 
integrity of the fitted filter.  
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80  HEPA-filtered  re-circulating  cabinets  do  NOT  absorb  or  capture  fumes,  gases  or 
vapours, for which external venting to a safe place would be required in addition to the HEPA 
filter. If corrosive vapours or fumes could be generated, a glass fibre rather than cellulose HEPA filter 
should be used and the exhaust vented to a safe place outside. 
81  The  International  Organization  for  Standardization  Technical  Report  (ISO/TR  12885)  on 
nanotechnology  proposes  a  series  of qualifications  on the  use  of  MSCs  based  on  their  mode  of 
operation and the quantity of nanomaterial that could be safely handled in them (Appendix 1).  
 82   If  using  a  re-circulating  safety  cabinet  or  re-circulating  MSC,  it  should  conform  to 
BS7989:2001 3 and the following must be considered: 
  The filter must be HEPA; charcoal filters alone must not be used
1.  
  The cupboard should have a filter blockage warning/alarm.  
  The cupboard must have a low airflow warning/alarm. 
  How a saturated filter is to be safely changed.  
  How the contaminated filter is to be safely disposed of (incineration is recommended). 
  The cupboard must be subject to regular maintenance including a filter integrity test.  
  The cupboard must be subject to thorough maintenance, examination and testing (including a 
filter integrity test) at periods not greater than fourteen months, and more frequently if the 
assessment identifies higher risk; every 6 months would be good practice. 
Maintenance, examination and testing of control measures 
83  Regulation 9 of COSHH requires that every employer who provides any control measure to 
meet the requirement of Regulation 7 shall ensure that it is maintained in an effective state, in an 
efficient working order and in good repair. 
84  In order to comply with Regulation 9 it should be ensured that: 
  All measures used to control exposure to nanomaterials are maintained in good working order 
and in good repair. (The manufacturer/supplier of plant should be able to help with appropriate 
information.) 
  Competent  persons  undertake  frequent  visual  checks  and  periodically  carry  out  thorough 
examinations of equipment to ensure they are being maintained adequately. 
  All LEV plant is examined and tested at least every 14 months (a record of such tests must be 
kept for at least 5 years after the date on which they were made). 
85  Further general information about LEV is contained in HSG 258. 
                                                           
1 Charcoal filters are designed to absorb vapours and fumes, for which they have a finite capacity. When the 
capacity is exceeded, contaminate is returned to the workplace. Charcoal filters alone are not designed for 
filtering solid materials and for these reasons the use of such systems should be avoided.  
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Personal Protective Equipment (PPE) 
Eye protection 
86  Suitable  eye  protection  must  be  worn  when  handling  any  chemicals  including  particulate 
nanomaterials (minimum of close fitting safety glasses).  
Respiratory protective equipment 
87  There will be situations where other control measures are either not reasonably practicable or 
fail to achieve adequate control. In these circumstances, the use of Respiratory Protective Equipment 
(RPE)  is  a  valid  control  strategy.  RPE  should  only  be  used  however  when  all  other  reasonably 
practicable measures have been taken but these have not, in themselves, achieved adequate control. 
88  It must be emphasised that the use of RPE as a means of preventing exposure should be a 
last resort (COSHH) and must not be undertaken lightly or without full consideration of the practicality 
of using engineering controls. 
89  Disposable  masks  (no  less  than  FFP3  standard)  are  only  suitable  as  a  secondary 
precautionary  measure  against  accidental  “spillage”  not  as  a  first  line  of  protection.  Full-face  P3 
APF40 (Assigned Protection Factor 40) particulate respirators that protect the eyes and lungs are 
required for any work in an atmosphere containing airborne-engineered particulate nanomaterials. 
90  All  RPE,  including  disposable  masks,  must  be  suitable  for  the  task,  manufactured  to  the 
appropriate standard and face-fit tested for the individual by a competent face-fit tester.  
91  Those using RPE should be trained in its use and if the equipment is re-usable, it should be 
regularly cleaned, checked to ensure that it remains effective and monthly maintenance records kept. 
For  further  information  on  the  selection,  use  and  maintenance  of  RPE,  see 
http://www.hse.gov.uk/coshh/basics/ppe.htm. 
Gloves 
92  The gloves selected should be suitable and manufactured to an appropriate standard. For 
many  particulate  nanomaterials,  good  quality,  disposable,  single-use  gloves  should  be  adequate. 
However consideration must also be given to other chemicals used in the procedure/process. Organic 
liquids, including solvents, can not only permeate through gloves quite quickly in their own right but 
may facilitate the penetration of small particulate nanomaterials through gloves. 
93  Glove  material  thickness  is  a  major  factor  in  determining  the  diffusion  rate  of  chemicals 
through gloves and consideration may need to be given to wearing two layers of disposable gloves for 
some  materials.    Guidance  on  choosing  the  appropriate  gloves  to  protect  skin  from  a  variety  of 
substances can be found at http://www.hse.gov.uk/skin/employ/gloves.htm. 
94  Currently  the  only  criteria  that  can  be  readily  accessed  to  validate  gloves  as  potentially 
suitable for use with particulate nanomaterials is the virus penetration test (ASTM F1671-97b/ISO 
16604),  which  uses  a  28  nm  diameter  bacteriophage.  If the  risk  assessment  indicates  that  latex 
gloves are the safest choice, then only low protein, powder-free gloves should be used. 
95  All those working with particulate nanomaterials should be properly trained in how to put on 
and remove gloves without contaminating themselves. Guidance on removing single-use gloves can 
be found on the HSE training video, available at: 
http://www.hse.gov.uk/skin/videos/gloves/removegloves.htm.  
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Protective clothing 
96  When  working  with  particulate  nanomaterials,  suitable  lab  coats,  coveralls  or  where 
appropriate,  disposable  overalls  should  be  worn.  Provision  must  be  made  to  allow  clean 
overalls/laboratory coats to be put on and dirty ones removed in a manner that does not contaminate 
the individuals or the general workplace.  
97  If dust exposure from contamination of work clothing could be significant, clothing made from a 
low dust-retention and low dust-release fabric such as polyethylene textiles is recommended. The 
European Nanosafe 2 project reported in 2008 that particulate nanomaterials can permeate through 
some intact disposable overall materials and by implication, woven reusable materials. The Nanosafe 
2  report  recommended  non-woven  Tyvek/Tychem  polyethylene  overalls  for  use  with  particulate 
nanomaterials in preference to paper or cotton.  
98  If re-usable laboratory coats or overalls are used, provision should be made for their regular 
laundering  and  the  prevention  of  secondary  exposure.  (In  the  event  of  a  “one-off”  gross 
contamination, consideration should be given to treating even “re-usable” PPE as disposable.) 
Cleaning spillages 
99  The  work  area  and  all  equipment  should  be  thoroughly  cleaned  after  use  or  following  a 
spillage by wet-wipe cleaning.   
  Do not brush. 
  Do not use compressed air for cleaning. 
  Do not use a standard vacuum cleaner.   
100  If  a  vacuum  cleaner  is  the  only  reasonable  practical  means  of  cleaning,  it  must  be  a 
dedicated,  commercial,  HEPA-filtered  cleaner  and  the  filter  regularly  changed  under  controlled 
conditions  that  contain  the  particulate  nanomaterial  dust  for  disposal  as  hazardous  waste.  The 
cleaner itself must only be used for this task and will need to be treated as hazardous waste at the 
end of its life, following the precautionary approach. 
 
Specific Advice for High Aspect Ratio Nanomaterials (HARNs)  
101  CNTs and some nanowires (as described in page 13) are substances of high concern and 
unless, or until, sound evidence is available on the hazards from inhalation, a strict precautionary 
approach should be taken to the risk management of all HARNs.  
102  If  the  use  of  HARNs  cannot  be  avoided,  then  the  implementation  of  a  risk  management 
programme  in  the  workplace  can  help  to  minimise  the  potential for  exposure  to  HARNs.  Such  a 
programme should include the following:  
  Assess the worker’s job and tasks to determine the potential for exposure.  
  Use  appropriate  work  processes,  systems  and  engineering  controls,  and  provide  suitable 
equipment and materials to minimise the likelihood of release i.e. minimise the amount of 
HARNs produced, or produce HARNs in a form that reduces the chance of them becoming 
airborne. Where possible, use equipment that fully encloses the process.   
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  Control exposure at source by carrying out all tasks, including packaging for disposal, in a 
ducted fume cupboard with a HEPA filter, or in other suitable LEV fitted with a HEPA filter. 
When using other types of LEV, try to enclose the process as much as possible. Ductless, 
HEPA filtered safety cabinets and re-circulating HEPA filtered Class I or III MSCs can be used 
with small quantities of CNTs ,and other HARNS  as long as they are subject to rigorous 
maintenance  and  checks  are  carried  out  to  ensure  they  are  effective  at  all  times.  See 
Appendix 2 for more information.  
  Reduce the number of employees handling HARNs and minimise the level and duration of 
exposure and the quantities used.  
  If possible, keep the material wet or damp to reduce the risk of it becoming airborne.  
  Provide RPE for  emergencies,  and only for  use in addition to other control measures. All 
employees  who  use  RPE  must  be  trained  and  have  had  face-fit  testing  performed.  HSE 
recommends RPE with an assigned protection factor (APF) of 40 or higher. 
  Provide  personal  protective  equipment  (e.g.  gloves,  non-woven  coveralls).  Use  single-use 
disposable gloves where possible. Glove material thickness is a major issue in determining 
diffusion  of  particulate  nanomaterials  and  therefore  at  least  two  layers  of  gloves  are 
recommended when handling HARNs. If the risk assessment indicates that latex is the safest 
choice, then only use low protein, powder-free gloves. Provide protective clothing such as 
polyethylene textiles (e.g. Tyvek) which performs better and does not retain dust or allow dust 
to penetrate - do not use wool, cotton or knitted material.  
  Consider maintenance, filter replacement, storage and disposal in risk assessments for the 
control of exposure to HARNs.  
  Use ‘wet-wiping’ wherever practicable for cleaning and avoid the use of vacuum cleaners. If 
vacuum cleaners are the only reasonably practical option, they must be appropriately HEPA 
filtered and decontaminated before further use. Contaminated wet wipes should be double 
bagged and treated as hazardous waste.  
  Emergency procedures should be in place to deal with spills, accidents and emergencies.  
  Educate and train workers in the proper handling of particulate nanomaterials (e.g. good work 
practices) and keep records of all training carried out.  
  
Information, Instruction and Training 
103  To comply with Regulation 12 of COSHH, employers should give all their employees who may 
be exposed to nanomaterials at work, sufficient information, instruction and training to understand the 
risks to their health caused by potential exposure to nanomaterials and the precautions that should be 
taken to avoid or minimise exposure.  
104   In academia, it is important that the person carrying out the research carries out risk and 
COSHH assessments and is trained in how to perform these tasks. A senior member of staff should 
check and sign them off, but should not write them per se. A central record of all health and safety 
training in COSHH and risk management should be kept within the department with or for students, 
and this can be used for future employment.  
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105  Employers  should  provide  adequate  supervision,  particularly  to  new  and  inexperienced 
workers.  The training  should  detail  how  control  measures  are  to  be  used.  Employees  should  be 
instructed to report any obvious defects in the control measures to their supervisor.  
106  Where RPE is used, employees should be trained to check that it fits properly, and given clear 
instructions about when it should be used, serviced or, if it is disposable, thrown away. 
107  Information, instruction and training should in particular enable employees to: 
  Understand the risks to health arising from exposure. 
  Use the control measures provided effectively. 
  Use PPE effectively where necessary. 
108  A  record  of  all  the  information,  instruction  and  training  should  be  kept  for  each 
employee. 
 
Monitoring  
109   One of the general principles of risk management includes taking measures to prevent or 
minimise exposure of workers to nanomaterials and their releases into the environment. Monitoring is 
important to assess whether potential exposure occurs and whether the engineering controls are 
adequate. Exposure to nanomaterials can occur by ingestion, skin penetration or inhalation. However, 
inhalation is the primary route of exposure for airborne particulate nanomaterials. There is currently 
no consensus on which is the most appropriate metric or method to measure airborne nanomaterials 
in  the  workplace.  Sampling  strategies  based  on  extensive  real-time  measurements  and  off-line 
characterisation  of  airborne  engineered  nanoparticles  have  been  described  in  PD  ISO/TR 
27628:2007,  ISO/TR  12885:2008,  PD6699-3:2010  and  Brower  et  al  (2009).  However,  workplace 
exposure measurement surveys based on extensive monitoring using a large set of sophisticated 
equipment require training and expert knowledge. 
 
110  Guidance  documents,  particularly  those  from  ISO/BSI  and  NIOSH  provide  recommended 
approaches to undertaking exposure monitoring. NIOSH has proposed the Nanoparticle Emission 
Assessment Technique (NEAT) (Methner et al, 2010a, and b) and the German Chemical Industry 
Association (VCI) has also developed a tiered approach for the assessment of exposure to particulate 
nanomaterials  in  workplaces.    Approaches  based  on  simple  to  use,  hand-held  instruments  have 
however been developed. 
Limitations to monitoring 
111  The monitoring of airborne particulate nanomaterials in the workplace is challenging due to the 
lack of portable and personal instruments that are selectively sensitive to engineered nanomaterials 
against a background of non-engineered nanomaterials (which can fluctuate). Background is defined 
as  airborne  particles  present  in  the  workplace  and  differs  from  engineered  particulate 
nanomaterials/nanomaterials released during manufacturing, use or handling. It includes “ultra-fines” 
originating from different sources including urban pollution.  
Instruments used 
112  The  sampling  method  described  in  Appendix  5  uses  hand-held  Condensation  Particle 
Counters (CPC) and Optical Particle Counters (OPC). Hand-held CPCs and OPCs measure particle 
number concentrations in the size range from 10-20 nm to 1 μm and 0.5 μm to about 15 μm or greater  
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respectively.  They  are portable,  easy  to  use, cost  effective  fast response  instruments  capable  of 
detecting transient releases. An electrostatic precipitator or a suitable filter substrate should be used 
to collect samples for analytical EM analysis.  
Sampling strategy 
113    The protocol described in Appendix 5 is designed to be a pragmatic first stage approach to 
rapidly  assess  particle  release  and  whether  the  control  measures  or  changes  implemented  are 
effective.  It requires at least a CPC, OPC and a sampler for subsequent EM analysis. All these 
instruments should be placed close to the task. Another CPC and OPC, positioned away from the 
task/process, can also be used. See Appendix 5 for more information. 
114  It is important that the background level of nanomaterials is established before any production 
or processing of the nanomaterial is started. This is because there is a natural background level of 
nanomaterials in the air, the amount of which will depend on the location. 
Limitations  
115  As  the  hand  held  CPC  and  OPC  instruments  in  their  basic  form  give  no  or  limited  size 
discrimination  in the  size  range  detected,  the  source must  be  “detected”  by  increased  in  particle 
counts  relative  to  the  background,  over  a  wide  size  range.  More  sophisticated  instruments  are 
available which offer much improved size discrimination which may help to better define the source 
but still rely on a comparison to the background count. Off-line EM analysis of the particles collected 
can confirm the presence or absence of the particles of concern. The performance and limitations of 
real-time instruments and samplers used for the monitoring of airborne particulate nanoparticles and 
the use of the data derived from them are not fully understood and is an area of active research. The 
protocol describes “current best practice”; however, given the developmental nature of this field in 
doubt, this approach should be supported by external expert advice where necessary.  
 
Health Surveillance  
116  On-going research on the hazards of engineered particulate nanomaterials is needed along 
with the continual reassessment of available data to determine whether specific medical screening is 
warranted for workers who are producing or using particulate nanomaterials. 
117  HSE proposes that best practice would involve keeping a record of all those staff who are 
working with particulate nanomaterials via the equivalent of a COSHH work activity record form, in a 
similar  way  to  other  substances  of  concern.  Alongside  such records  of  work  activity,  the  type  of 
particulate nanomaterials handled, the duration of work with the material, and the exposure scenarios 
should be documented. An example of a work activity record can be found in Appendix 4. 
118  Health screening and health surveillance specific for hazardous particulate nanomaterials are 
not practical at the present time due to a lack of information about anticipated health effects and 
suitable biomarkers. 
119  The health hazards related to the material, irrespective of the nanoscale form, should still be 
considered as part of the usual COSHH risk assessment. This should be informed by considering the 
likely routes of exposure for the material of concern. 
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Disposal of Waste Nanomaterials  
120  There  is  currently  no  waste  regulatory  framework  in  the  UK  specific  for  nanomaterials. 
Nonetheless, the Environmental Protection Act 1990 (Duty of Care) and Waste (England and Wales) 
Regulations 2011 (in Scotland, the Waste Management Licensing Regulations 2011, and in Northern 
Ireland, the Waste Regulations (Northern Ireland) 2011) apply. 
121  The responsibility under UK law of any individual who is the holder of controlled waste is to 
ensure that the waste is managed properly, is recovered or disposed of safely, does not cause harm 
to human, animal or plant health or pollution of the environment, and is transferred only to someone 
who is authorised to receive it. However, not all nanomaterial waste will be classed as “hazardous 
waste”;  for  example,  nanomaterials  bound  in  a  solid  matrix  or  on  a  surface  are  unlikely  to  be 
hazardous. It is recommended that materials that contain nano pores (e.g. a surface template for 
nanomaterial deposition) are not considered as nanomaterial waste and disposal of these materials 
should follow standard hazardous waste disposal routes where applicable. 
122  For larger consignments of waste nanomaterials (for example, from manufacturing), see PAS 
138:2012. 
123  The fate of nanomaterials in the environment, an obvious concern (RSC, 2006) is outside the 
scope of this guidance: however, a summary is available (CEP 2008).  
124  Determining the method of waste disposal for nanomaterials is dependent on the nature and 
character of the nanomaterial waste; for example, whether the nanomaterial waste is in solid or liquid 
form. Raw nanomaterial presents a greater hazard than a solid matrix impregnated with nanomaterial 
owing to the increased risk of exposure. It is important that nanomaterial  waste  is identified and 
characterised  (for  example,  dust  filters  contaminated  with  CNTs  or  HARNs,  paper  tissues 
impregnated with colloidal silver, metal oxide nanomaterials on carbon black), in order to determine 
which controls are needed to reduce the risk of exposure. 
125  Drawing on previous guidance (MIT, 2008) nanomaterial waste can be broadly classified into 
the following waste streams: 
  Pure nanomaterials (for example, CNTs). 
  Items contaminated with nanomaterials (for example, wipes/paper towels). 
  Liquid suspensions containing nanomaterials (for example, colloids). 
  Solid matrices with nanomaterials that are friable or attached to the surface. 
  Nanomaterials embedded in a solid matrix that are unlikely to be released on contact with air 
or water: i.e. the nanomaterial is immobilised. 
126  The level of controls necessary to dispose safely of nanomaterial waste will depend on its 
nature. Unless there is evidence that the materials to be disposed of do not present any hazards, a 
precautionary approach should be taken for handling, packaging and disposal. Waste should be 
disposed of in such a manner that the risk of exposure to the nanomaterials is minimised. 
127  It is recommended that waste nanomaterials or waste containing nanomaterials is double-
bagged or doubly contained,  labelled, and sealed in preparation  for  disposal.  (A consensus view 
OECD 2010).  
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Preparation of nanomaterial waste prior to disposal 
128  The risk of exposure to hazardous particulate nanomaterial waste must be either prevented or 
controlled;  wherever  possible,  particulate  nanomaterial  waste  should  be  either  immobilised  or 
contained. The disposal of nanomaterials irreversibly embedded in substrates or non-soluble media 
may be risk assessed separately following a precautionary approach. 
129  Containment  can  be  achieved  by  employing  suitable,  sturdy,  compatible  containers  (for 
example, plastic, clip top containers), which prevent the escape of nanomaterials. Containers must be 
clearly labelled, providing a description of the waste and including the hazardous properties (either 
known or suspected). 
130  In general, as well as the particulate nanomaterials, laboratory consumables such as paper 
towels, wipes, disposal gloves and suits, blotters and other moderately contaminated items should be 
double-bagged in preparation for disposal (i.e. transfer to the waste contractor for incineration). It is 
recommended that:  
  Prior to disposal, the contaminated waste is placed in a sealable, plastic bag inside a fume 
hood/ biosafety cabinet. 
  The sealed bag should then be placed inside another sealable, plastic bag and clearly labelled 
identifying the contaminated material. 
131  It  is  suggested  that  where  possible,  contaminated  liquid  and  solid  waste  is  treated  in  an 
appropriate  way  to  inactivate  the  nanomaterial  (OECD,  2010).  For  example,  contaminated  liquid 
waste can be placed in a waste solvent stream (ultimately incinerated), fixed in a resin (Cornelissen, 
2011)  or  adsorbed  on  to  a  solid  substrate  (for  example,  silica  or  carbon).  Other  examples  of 
inactivation  include:  aggregating  the  nanomaterial  in  solution  (for  example,  by  centrifuging  gold 
nanomaterials), or dissolving the nanomaterial in solution (for example, treating silver nanomaterials 
with aqua regia (a mixture of hydrochloric acid and nitric acid)). Solid nanomaterial waste can be 
included in existing solid hazardous waste streams, for example, mixed with waste silica (hazardous 
by virtue of potential inhalation) and double-bagged, sealed and transferred into a suitable sealable 
container (for example, a metal or plastic clip top drum). 
132  Where  surfaces  or  materials  have  been  decontaminated  (for  example,  wiped  or  washed 
down),  producing  a  contaminated  residue,  it  is  recommended  that  the  resulting  residue/waste  is 
treated as chemical waste (hazardous waste) (Cornelissen, 2011).   
133  Nanomaterials should not be disposed of via normal (non-hazardous) disposal routes (through 
normal  waste  to  landfill  or  drains)  unless  it  can  be  demonstrated  that  disposal  via  these  waste 
streams is safe and does not contravene environmental legislation. The precautionary approach 
has been generally adopted: no free nanomaterials should enter any non-hazardous waste stream or 
be disposed of via the drains (Cambridge, 2011). 
Disposal by waste contractors 
134  There is a legal obligation to comply with the Environmental Protection Act 1990 (Duty of 
Care) which requires that any waste for disposal should be fully described and this should include the 
presence  of  nanomaterials  where  there  is  any  uncertainty  to  the  risk  they  might  pose.  Further 
information is available from www.environmental-agency.gov.uk/netregs/62529.aspx. 
135  The Environmental Agency guidance (EA, 2011a), which has recently been amended to reflect 
the revised Waste Framework Directive 2008, identifies whether waste is hazardous or not; if there is  
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insufficient evidence to demonstrate that the waste is non-hazardous, then according to the EA’s 
guidance, the waste is classed as ‘hazardous’. 
136  The  EA  guidance  (EA,  2011b)  states  threshold  limits  of  ≥0.1%  for  both  very  toxic  (T
+)
‡  
substances by inhalation or skin absorption and Category 1 & 2 carcinogens, and a limit of ≥3 % for 
toxic  materials  by  mass  in  ‘bulk’.  It  is  yet  to  be  determined  if  this  approach  is  applicable  to 
nanomaterial waste. It has been suggested [PD 6699-2:2007] that most nanomaterial waste will fall 
into either “H5” or “H6” waste categories, i.e. ‘harmful’ or ‘toxic’ respectively if inhaled, or ingested, or 
adsorbed through the skin. In some cases, ascribing waste to either “H7” (carcinogenic) or “H13” 
(sensitizing) categories may be applicable as well. 
137  Incineration of solid waste containing nanomaterials has been identified as the “conservative 
option” even though the nanomaterials are present at low levels (<1%) (HSE, 2004). With respect to 
CNTs, high temperature (>500 ºC) incineration is the recommended method of disposal (HSE, 2009). 
Table 2: Summary of treatment and control conditions for waste nanomaterials 
Waste 
nanomaterial (NM) 
Pre-treatment 
prior to disposal 
Containment  Level of 
engineering 
controls 
Disposal method 
Raw NM (free 
nanoparticles) 
Wet/moisten  Double   Inside a hood or 
glove box 
Incineration 
Contaminated 
solids (laboratory 
consumables) 
Wet/ moisten if 
necessary 
Double bag 
(plastic, 
sealable) 
Inside a hood or 
glove box 
Incineration 
Liquid solutions 
(colloids/blends/QM 
Dots) 
Mix with solvent 
waste stream. 
 
Aggregate 
nanoparticles 
 
 
Dissolve NP (form 
ions) 
Drip tray/funnel 
 
 
Vial/container/
drip tray 
 
 
Vial/container/
drip tray 
Inside a hood 
 
 
Inside a hood, 
and/or 
contained in a 
centrifuge. 
 
Inside a hood 
Incineration 
 
 
Mix with solid waste. 
Incinerate 
 
Either mix with other 
soluble waste or 
dilute to drain.  
NM bound in resin 
in or polymer 
As for liquid 
solutions or 
package. 
As for liquid 
solutions or 
double 
containment. 
Inside a hood  Incineration 
 
NM in a solid matrix 
but friable 
Wet/moisten  Double 
containment 
Inside a hood  Incineration or 
licensed landfill. 
NM in a solid matrix 
not friable 
None  Single 
containment 
General 
ventilation 
Incineration or 
licensed landfilll. 
                                                           
‡  Note: ‘Very Toxic,(T
+)’ under Global Harmonised System (GHS)  Acute Categories 1&2 and ‘Toxic, (T)’   
Acute Category 3; Chronic Specific Target Organ Toxicity (STOT), (single and repeated exposure) Category 1; 
Germ Cell Mutagenicity, Carcinogenicity, Reproductive Toxicity are all Categories 1A & 1B.  
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Labelling and Signs 
138  A  requirement  and/or  standardised  approach  to  labelling  and  safety  signs  for  use  with 
nanomaterials does not currently exist. It is recommended that a diligent approach is taken using, for 
example,  existing  risk  and  safety  phrases  and  warning  signs  to  provide  adequate,  relevant  and 
specific information on any actual or potential hazards and safety risks. 
 
139  Risk and safety phrases are used to convey information derived from the hazard, exposure 
and risk assessments, in Safety Data Sheets (SDS) and COSHH  assessments. Derived from the 
Chemicals (Hazard Information and Packaging for Supply) (CHIP) Regulations, they are sequenced in 
numerical order and prefaced with “R” for risk phrases and “S” for safety phrases. The current lists of 
R  and  S  phrases  are  available  from  sources  including  the  UK  Health  and  Safety  Executive 
(http://www.hse.gov.uk/chip/phrases.htm) along with frequently used combinations. 
 
140  The European Regulation (EC) No 1272/2008 on classification, labelling and packaging of 
substances and mixture (CLP) came into force in all EU member states, including the UK in 2010. 
The  CLP  Regulation  adopts  the  Globally  Harmonised  System  (GHS)  on  the  classification  and 
labelling of chemicals and will replace CHIP from 1 June 2015.  Although the CLP hazard pictograms 
are very similar to the CHIP hazard symbols, they have a new shape, new design and a new colour. 
 
141  GHS aims to bring together the various national and regional hazard communication systems 
that control the supply of hazardous chemicals and to ensure that information on physical hazards 
and  chemical  toxicity  is  available  in  order  to  enhance  the  protection  of  human  health  and  the 
environment during the handling, transport and use of these chemicals. Activity associated with GHS 
may, in the future, provide a consistent approach for labelling of nanomaterials, but the assignment of 
risk and safety phrases will always be contingent upon consideration of the hazardous nature of the 
material where data are available, and in the absence of data, will require a precautionary approach. 
142  The  selection  of  appropriate  hazard  labels,  signs  or  pictograms  should  be  based  on  the 
available hazard information for the material. In the absence of information, a precautionary approach 
to labelling should be adopted.   
143  Ad hoc signs or pictograms should be posted in areas to provide visual indication of local 
instructions  or  rules  in  place,  for  example,  on  storage  cabinets,  fume  cupboards,  instruments 
dedicated for use with nanomaterials. The content and format of the signs should be consistent with 
any in-house requirements. 
144  Generic pictograms, adopting the format of the yellow/orange warning triangle, have emerged 
for “nanomaterial hazards” and whilst these have no official recognition by authorities, their use may 
be  considered  to  provide  a  visual  indication  of  the  presence  of  nanomaterials,  as  appropriate.  It 
should be noted that these generic signs do not provide any information on the nature of the hazard, 
and any known or suspected hazards (e.g. oxidising, explosive) should be adequately indicated.  
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APPENDIX 1: Comparison of US Microbiological Safety Cabinet characteristics 
and applicability for nanomaterials 
The International Organisation for Standardisation Technical Report (ISO/TR 12885) with respect to the use 
HEPA filtered cabinets for nanomaterials. 
  Applications 
MSC 
Class 
Face 
Velocity m/s  Airflow Pattern  Non-volatile Toxic 
Chemicals 
Volatile Toxic 
Chemicals 
I*  0.4  In at front then through HEPA to the 
outside or recirculate into the room 
through HEPA. 
Yes  When exhausted 
outdoors 
1,2 
II, A1  0.4  70% recirculated to the cabinet work 
area through HEPA; 30% balance 
can be exhausted through HEPA 
back into the room or to outside 
through a canopy unit. 
Yes 
(minute amounts) 
No 
II, B1  0.5  30% recirculated, 70% exhausted.  
Exhaust cabinet air must pass 
through a dedicated duct to the 
outside through a HEPA filter. 
Yes  Yes 
(minute 
amounts)
1,2 
II, B2  0.5  No recirculation; total exhaust to the 
outside through a HEPA filter. 
Yes  Yes 
(small amounts)
 1,2 
II, A2  0.5  Similar to II, A1, but has 100 lfpm 
intake air velocity and plenums are 
under negative pressure to room; 
exhaust air can be ducted to outside 
through a canopy unit. 
Yes  When exhausted 
outdoors  
(Formerly "B3") 
(minute amounts)
 
1,2 
III  N/A  Supply air is HEPA filtered. Exhaust 
air passes through two HEPA filters 
in series and is exhausted to the 
outside via a hard connection. 
Yes  Yes 
(small amounts)
 1,2 
 
1.  Installation may require a special duct to the outside, an in-line charcoal filter, and a spark proof (explosion proof) motor and other 
electrical components in the cabinet. Discharge of a Class I or Class II, Type A2 cabinet into a room should not occur if volatile chemicals 
are used. 
2.   In no instance should the chemical concentration approach the lower explosion limits of the compounds. 
(Taken  from  Appendix  A  of  ISO/TR  12885,  Technical  Report:  Nanotechnologies  -  Health  and  safety  practices  in 
occupational settings relevant to nanotechnologies. Which in turn cites its source as the US Department of Health and 
Human Services publication ‘Biosafety in Microbiological and Biomedical Laboratories, 2007’) 
*A Class I microbiological safety cabinet is similar in operation to a HEPA filtered fume cupboard or HEPA filtered cabinet, 
drawing in air through the front opening before HEPA filtering the exhaust.   
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APPENDIX 2: Particulate Nano-Material Control Measures Selection Flowchart
 
Control types
A - Capturing hood, ideally discharged to a safe place outside. HEPA
filtration to be used if recirculated back to the workplace.
B - Partial enclosure with HEPA filtration with recirculation to the workplace
C - Partial enclosure with discharge to a safe place outside.e.g fume
cupboard or a well designed bespoke partial enclosure
D - full enclosure with HEPA filtration and discharged to a safe place outside.
Bound in a matrix Dry and free
Suspended in a
solution
Will matrix be cut
or abraded?
Abraded/cut by
hand
Yes
No
Abraded/cut using
power tools
Use minimum of
Type A control
Use minimum of
Type B or C
control
Nano material
state
Could an aerosol
be produced?
Follow Good
Practice
No
Yes
Intentional?
No
Yes
Are any substances
 used toxic corrosive, flammable,
carcinogenic, mutagenic, a
substance toxic to reproduction,
CNT, biopersistent HARN
or a sensitiser?
Use minimum of
Type B or C
control
Use minimum of
Type C with HEPA
or D control
No Yes
Use minimum of
Type B or C
control
Are NPs to be
made airborne
deliberately?
No further action
required
Are any substances
 used toxic corrosive, flammable,
carcinogenic, mutagenic, a
substance toxic to reproduction,
CNT, biopersistent HARN
or a sensitiser?
Could NPs
become airborne
inadvertently?
No
No
Follow Good
Practice
Use minimum of
Type B or C
control
Yes
Yes
Use minimum of
Type D control
No
Use minimum of
Type B or C
control
Will NPs be
extracted and
dried?
Yes
Follow Good
Practice
Follow Good
Practice
Follow Good
Practice
Follow Good
Practice
Yes
No 
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APPENDIX 3: Engineering Controls  
Local Exhaust Ventilation (LEV):  
Conventional ducted fume cupboards fitted with HEPA filtration and ducted microbiological safety cabinets 
may be used for HARNs, see below.  
Fume cupboards  
A  fume  cupboard  is  an  enclosure  designed  to  contain  and  exhaust  vapours  and  gaseous  contaminants 
generated  inside  it.  A  fume  cupboard  is  a  key  engineering  control  device,  therefore  the  selection  of  the 
appropriate fume cupboard design and the adherence to safe work practices are crucial to user safety.  
For  use  with  HARNs  the  fume  cupboard  exhaust  air  should  be  HEPA  filtered,  and  wherever 
reasonably practicable vented to a safe place outside.  
It is important that a fume cupboard complying with BS EN 14175-4:2004 is used and that the fume cupboard 
does not lose containment during normal use. In most circumstances, velocity measurements and smoke test 
will show  whether the fume cupboard  is effective. Smoke tests, with appropriate detection, can be used to 
investigate a number of problems, such as:  
  irregular air-flow and eddy characteristics resulting in air movement out of the cupboard,  
  the possible negative effects of equipment on airflow ,  
  the possible negative effect of heat sources within the cupboard on airflow  
  leakage from the cupboard or ducting.  
However, if there is any doubt about the integrity of the fume cupboard then it may be necessary to carry out a 
containment test as in BS EN 14175-4:2004.  
Installation of fume cupboards must be only be undertaken by those with knowledge of British Standard 
BS  EN  14175-5:  2004  ‘Fume  cupboards,  recommendations  for  installation  and  maintenance’.    In 
particular fume cupboards must not be sited:  
  On heavy pedestrian traffic routes  
  Adjacent to doors  
  Adjacent to opening windows  
As the above can cause air turbulence and wake affects that can affect the cupboards containment  
  At the open end of a u-shaped laboratory bay, since a fire or explosion within the cupboard, may trap 
workers in the bay.  
Microbiological safety cabinets  
Ducted microbiological safety cabinets can be used*. The Class II and III microbiological safety cabinets, 
unlike  the  Class  I  type,  provide  protection  for  both  the  user  and  the  material  in  the  cabinet  is  working 
environment. All these cabinets exhaust air through a HEPA 14 filter.  
*It  should  be  noted  that  a  Class  II  cabinet  is  not  suitable  for  handling  HARNs  because  it  re-
circulates up to 70% of its air.   
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Ductless  recirculating  HEPA  filtered  safety  cabinets  and  recirculating 
microbiological safety cabinets  
Safety cabinets and microbiological safety cabinets which recirculate air from the cabinets interior, thorough a 
HEPA  14  filter,  back  into  the  laboratory  can  be  used  for  small  quantities  of  HARNs  in  the  absence  of 
hazardous vapours or gases.  
If  using  a  recirculating  safety  cabinet  or  recirculating  microbiological  safety  cabinet  the  following  must  be 
considered; Cupboard must conform to British Standard BS 7989:2001.3. 
  The filter must be HEPA; charcoal filters alone must not be used
†.  
  The cupboard should have a filter saturated warning/alarm.  
  The cupboard must have a low airflow warning/alarm. 
  How is a saturated filter to be safely changed?  
  How is the contaminated filter to be safely disposed of? (incineration)  
  Ensure that the filter integrity test is performed.  
  Subjected to thorough examination and testing at periods not greater than fourteen months and more 
frequently if the assessment identifies higher risk; every 6 months would be good practice.  
Charcoal filters are designed to absorb vapours and fumes, for which they have a finite capacity. When the 
capacity is exceeded, contaminate is returned to the workplace. Charcoal filters alone  are not designed for 
filtering solid materials and for these reasons the use of such systems should be avoided.  
Users should take steps to ensure that the standard of supervision, training, system of work and record keeping 
is  up  to  date.  The  safety  cabinet  should  be  set  aside  for  use  with  HARNs  or  chemically  similar  materials 
because some other chemicals may affect the effectiveness and integrity of the fitted filter.  
NB: HEPA filtered recirculating cabinets do NOT absorb or capture fumes, gases or vapours, for 
which external venting to a safe place would be required in addition to the HEPA filter.  
HEPA filter recirculating fume cupboards or cabinets can be used to control any potentially airborne ‘dusty’ 
hazardous substance as long as it is subjected to a rigorous risk assessment BUT should only be considered 
where external venting to a ‘safe place’ is not reasonably practicable. 
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APPENDIX 4: Record of Work Activity Form 
 
Record of Work Activity Using Nanomaterials 
 
COSHH Regulations require all individuals working with substances that can cause certain 
identifiable diseases or adverse health effects to be monitored. As a pre-cautionary measure 
the employer requires the completion of a Record of Work Activity for all individuals working 
with  
 
  Nanomaterials (particles of approximately 100 nm or less in at least one dimension) with 
unknown toxicological properties. 
 
For further information on the criteria for health surveillance see the HSE website: 
http://www.hse.gov.uk/coshh/basics/surveillance.htm 
 
Personal Details 
Surname:  Forenames: 
Male/Female:  Date of Birth: 
N.I. Number: 
Date commenced present job: 
Permanent address: 
Postcode:   Dept Tel No: 
Status: Staff/Undergraduate student/Postgraduate student/Visitor/Other (Delete as appropriate) 
Department: 
Supervisor’s name and contact telephone number: 
Signed:   Date: 
PLEASE COMPLETE SUBSTANCE DETAILS OVERLEAF 
THIS RECORD MUST BE KEPT BY THE DEPARTMENT FOR 40 YEARS 
FOLLOWING THE INDIVIDUAL LEAVING EMPLOYMENT.  
 
SUBSTANCE DETAILS 
Name of substance  Nature of hazard
1  Physical state
2  Quantity, amount
3 
Frequency/duration 
of use
4 
Control measures 
in use
5 
 
 
 
         
 
 
 
         
 
 
 
         
 
 
 
         
 
 
 
         
 
 
 
         
 
 
 
         
 
1  Carcinogen, mutagen, substance toxic to reproduction, respiratory sensitiser, skin sensitiser or ‘nanomaterial of unknown toxicity’  
2  Powder, liquid, solid –this includes free nanoparticles, nanoparticles in liquid suspension or nanoparticles in a solid matrix  
3  Include amount and units 
4  Daily, weekly, monthly, rarely 
5  Fume cupboard, laminar flow bench, Local Exhaust Ventilation (LEV), glove box or other form of containment, personal protective equipment (please 
specify)  
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APPENDIX  5:  Sampling  Protocol  to  assess  release  of  particulate 
nanomaterials to the air 
This protocol was designed to assess the release of particulate nanomaterials into workplace air 
allow the effectiveness of the controls to be checked and if necessary to confirm that exposure 
to  the  particles  of  concern  was  taking  place.    Positive  results  should  trigger  a  review,  and 
improvement  of  the  control  approaches  used.  Other  more  comprehensive  strategies  (e.g. 
Brouwer ref) are described in the literature which may give improved on-line discrimination.  
Given the developmental nature of this field of measurement, the detection limits for any of the 
strategies are not yet well-defined. 
Real time measurements    
1   An initial assessment without the process / task running should be carried out. A CPC 
and an OPC are moved around to investigate any other potential sources of non-engineered 
nanomaterials and the range in the background concentration. If possible these sources should 
be isolated or stopped during the monitoring period. 
2  Measurements using a CPC and an OPC should be carried out before, during and after 
the activity under study takes place. The CPC and the OPC are stationary and positioned close 
to the worker’s task (within an approximate 1m radius of the worker’s head) taking care that 
they do not hinder or interfere with the workers’ normal duties.  Non-activity periods (before and 
after the activity period) should be monitored for at least 15 minutes if possible.  
3  Measurements using a second CPC and a second OPC could be carried out before, 
during and after the activity under study takes place.  The instruments are stationary and should 
be located at a distance from the activity, such that it measures airborne particle concentrations 
that are representative of the background concentration near the activity. A distance of at least 
2  m  is  suggested.  The  non-activity  periods  (before  and  after  the  activity  period)  should  be 
monitored for at least 15 minutes if possible.  
4   A CPC could also be used with the telescopic probe attachment to monitor particle 
number concentration inside containment/fume cupboards during activity periods. 
5  Be aware that any other extraneous sources of non-engineered nanomaterials such as: 
passing  lorries/fork  lift  trucks,  electric  motors,  smoke-generating  systems,  welding/soldering 
activities, open doors and windows can influence particle concentration readings greatly.  
6  Smoke  tubes,  for  the  testing  of  fume-cupboards  or  local  exhaust  ventilation  (LEV) 
efficiency, should not be used during the monitoring of the activities. It has been shown during 
previous  studies  that  these  can  be  a  source  of  very  high  concentrations  of  airborne  non-
engineered nanomaterials. 
7  All instruments should be calibrated at least every year and regularly checked to ensure 
consistent  operation  especially  their  performance  to  each  other  if  several  of  the  same 
instruments are used.  
Collection of samples for electron microscopy analysis 
8  A number of sampling techniques for the collection of airborne particles and subsequent 
electron microscopy analysis are available and include:  
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  Filtration  onto  filters  or  carbon  films  supported  on  transmission  electron  microscopy 
(TEM) grids using conventional sampling pump. TEM grids with a holey carbon film can 
be  attached  to  filters.  Filters  can  be  pre-  coated  with  gold  for  subsequent  scanning 
electron microscopy (SEM) analysis.  
  Precipitation using thermal or electrostatic precipitators. 
9  A sampler should be positioned close to the activity/process and at a distance of at least 
2m from the process/task (optional) alongside the CPCs and OPCs. Samples collected inside 
containments/fume-cupboards  are  also  very  useful  for  comparison  with  samples  collected 
outside containments/fume-cupboards. 
Record and contextual information  
10  The times at which the monitors and samplers were started and stopped together with 
the sampler flow rates should be recorded. It is also critical that detailed contextual information 
of  all  activities  before,  during  and  after  the  task/process  takes  place  are  recorded  as  an 
increase in particle number concentrations from the real-time instruments may be unrelated to 
the task/process.  
Interpretation of Results 
11     Particle number concentration should be plotted and arithmetic means, minimum and 
maximum  concentrations  before,  during  and  after  the  task/process  should  be  calculated.  A 
difficult question to answer is if an increase in particle number concentration means there has 
been a corresponding emission of engineered nano-objects from the task/process. For that, the 
“task/process”  particle  number  concentration  must  be  higher  than  the  “background”  particle 
number concentration and this increase has to be statistically significant. However some critical 
judgement should also be applied. The background may greatly fluctuate or it can gradually 
increase or decrease with time. The contextual information is important in this decision-making 
as well as knowing whether other sources of non-engineered nano-objects are present. The EM 
analysis of the sample will confirm the presence or absence of the engineered nano-objects and 
if necessary may be used to quantify the number concentration and size distribution.     
 
 